• Home
  • About Us
  • Leadership Team
  • news
  • Careers
  • facility
  • Contact Us
  • news
  • Careers
  • facility
  • Contact Us
  • Home
  • About Us
  • Leadership Team
  • CAREERS

You are here

Home » News

News

THERAPURE RECEIVES $20 MILLION FROM FEDDEV ONTARIO’S ADVANCED MANUFACTURING FUND
07/24/2015
THERAPURE INNOVATIONS RECEIVES FDA APPROVAL TO PROCEED WITH A PHASE 1 CLINICAL TRIAL OF THE TARGETED LIVER CANCER THERAPEUTIC TBI 302
05/21/2015
Therapure Biomanufacturing Receives Four CMO Leadership Awards in Quality, Reliability, Productivity and Regulatory Categories
03/20/2015
Therapure Biomanufacturing Receives Four CMO Leadership Awards in Quality, Reliability, Productivity and Regulatory Categories
03/20/2015
THERAPURE INNOVATIONS RECEIVES FDA APPROVAL TO PROCEED WITH A PHASE 1 CLINICAL TRIAL OF ITS NOVEL ANEMIA THERAPEUTIC TBI 304H
03/13/2015
Therapure Biopharma Inc. Ranks within the Top 5% on the 2014 PROFIT 500 List of the Fastest Growing Companies in Canada
06/13/2014
Therapure Biomanufacturing Awarded Manufacturing Contract for Insmed’s ARIKAYCE™
04/29/2014
Therapure Biopharma Inc. Recognized for Innovation & Leadership at IAIR Awards in New York
04/22/2014
THERAPURE BIOPHARMA INC. HAS ACQUIRED PLASMA PROTEIN PURIFICATION TECHNOLOGY FROM UPFRONT CHROMATOGRAPHY A/S
12/03/2013
Therapure Biopharma Inc. wins a 2013 CMO Leadership Award in All 5 Categories: Quality, Reliability, Innovation, Productivity and Regulatory
09/11/2013

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • next ›
  • last »
  • News

Disclaimer | Privacy Policy | Contact Us | Accessibility
Privacy Policy | HTML Site Map

Vendor/Supplier Purchase Terms and Conditions
Copyright ©2015 Therapure Biopharma Inc.
Therapure Biomanufacturing, Therapure Innovations and Evolve Biologics are divisions of Therapure Biopharma Inc.

EVENTS

more

NEWS

more

awards

more
☒

Therapure CDMO is now a part of Resilience!

The CDMO assets of Therapure Biopharma Inc have been acquired by Resilience Biotechnologies, Inc., a wholly owned Canadian subsidiary of National Resilience, Inc. (Resilience), a U.S. based biopharmaceutical manufacturing and technology company.


We remain committed to supporting you as Resilience Biotechnologies Inc.




For more information about Resilience, please visit: https://resilience.com




MAKING THE FUTURE OF MEDICINE POSSIBLE